Skip to main content
. 2015 Sep 15;12(1):65–66. doi: 10.1200/JOP.2015.005660

FIG 2.

FIG 2.

Percentage of patients (N = 928) with solid tumors who had excessive tumor marker testing in 1 month (> one test in 1 month). (*) Maximum number of tests over 1-month period. AFP, α-fetoprotein; CEA, carcinoembryonic antigen.